title: Partial Remission of Hepatic Metastatic Lesion but Complicated with Secondary and Refractory Fever Lead by Nivolumab in a Patient with Lung Adenocarcinoma Presenting Gefitinib Acquired Resistance.
authors.forename: Zeng-Zhi
authors.initials: ZZ
authors.lastname: Lian
authors.forename: Yi-Feng
authors.initials: YF
authors.lastname: Sun
authors.affiliation: Department of Respiratory Medicine, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215006, China.
authors.forename: Cheng
authors.initials: C
authors.lastname: Chen
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy*; D000077192:Adenocarcinoma of Lung; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D019008:Drug Resistance, Neoplasm; D005260:Female; D005334:Fever / Q000139:chemically induced*; D000077156:Gefitinib; D006801:Humans; D008113:Liver Neoplasms / Q000556:secondary*; D008175:Lung Neoplasms / Q000188:drug therapy*; D008875:Middle Aged; D000077594:Nivolumab; D011799:Quinazolines / Q000627:therapeutic use*
chemical_list: D000911:Antibodies, Monoclonal; D011799:Quinazolines; D000077594:Nivolumab; D000077156:Gefitinib